INFLUENCE OF RESERPINE ON THE PITUITARY CONTENT OF MELANOCYTE-STIMULATING HORMONE AND ON HYPOTHALAMIC FACTORS WHICH AFFECT ITS RELEASE

1968 ◽  
Vol 42 (4) ◽  
pp. 505-512 ◽  
Author(s):  
MARIA E. TOMATIS ◽  
S. TALEISNIK
Keyword(s):  
Median Eminence ◽  
Normal Values ◽  
Male Rats ◽  
Normal Male ◽  
Melanocyte Stimulating Hormone ◽  
Inhibiting Factor ◽  
Pituitary Glands ◽  
Stimulating Hormone

SUMMARY The melanocyte-stimulating hormone (MSH) content of whole toad pituitary glands decreased upon treatment with reserpine. With daily injections the values remained low for 1 week but regained normal levels after 2 weeks in spite of an increased secretion of MSH as indicated by darkening of the skin. In rats a drop in pituitary MSH content also occurred after reserpine injection but normal values were found after 7 and 14 days of treatment. MSH-releasing factor found in stalk-median eminence tissue of normal male rats was not present in the reserpine-injected animals, but after 7 days of treatment an increase in MSH-release-inhibiting factor (MSH-R-IF) was demonstrated. MSH-R-IF was also found to have increased in female castrated rats after 2 days of treatment with reserpine. It is concluded that reserpine permits the secretion of pituitary MSH by blocking the release of MSH-R-IF, which accumulates in the hypothalamic neurones.

EFFECT OF HYPOTHALAMIC LESIONS ON PITUITARY MELANOCYTE-STIMULATING HORMONE

1967 ◽  
Vol 39 (4) ◽  
pp. 485-NP ◽  
Author(s):  
S. TALEISNIK ◽  
J. DE OLMOS ◽  
R. ORÍAS ◽  
MARÍA E. TOMATIS
Keyword(s):  
Median Eminence ◽  
Male Rats ◽  
Posterior Lobe ◽  
Melanocyte Stimulating Hormone ◽  
Mammillary Bodies ◽  
Hypothalamic Lesions ◽  
Paraventricular Nuclei ◽  
Inhibiting Factor ◽  
Electrolytic Lesions ◽  
Stimulating Hormone

SUMMARY The effect on the content of melanocyte-stimulating hormone (MSH) activity in the pituitary of electrolytic lesions placed in different regions of the hypothalamus was studied in male rats. Lesions in the paraventricular nuclei resulted, after 15 days, in a decrease of pituitary MSH activity to 20·4 ± 4·5%/mg. gland as compared with the controls, without changes in the weight of the hypophyses. In a group of animals in which the lesions failed to destroy the paraventricular nuclei completely the MSH activity in the pituitary was 66·4 ± 7·5% of that of controls and the weight of the gland was significantly higher. Hypothalamic lesions in the median eminence of the tuber cinereum produced 24 hr. later a decrease of pituitary MSH activity to 6·6 ± 0·8%, but 15 days later the values/mg. gland were almost normal. Lesions placed in the mammillary bodies or in the nucleus caudatus did not affect pituitary MSH content. Extracts of stalk-median eminence or posterior lobe from animals with lesions in the paraventricular nuclei, failed to show MSH-releasing factor as it is found in intact animals, nor did they contain MSH-release-inhibiting factor. The results support the concept that the paraventricular nuclei are involved in the control of pituitary MSH secretion and suggest that the MSH content of the disconnected hypophysis is to some degree regulated autonomously.

Effects of α-Melanocyte-Stimulating Hormone on Magnocellular Oxytocin Neurones and their Activation at Intromission in Male Rats

2006 ◽  
Vol 18 (9) ◽  
pp. 685-691 ◽  
Author(s):  
C. Caquineau ◽  
G. Leng ◽  
X. M. M. Guan ◽  
M. Jiang ◽  
L. Van der Ploeg ◽  
...  
Keyword(s):  
Male Rats ◽  
Melanocyte Stimulating Hormone ◽  
Oxytocin Neurones ◽  
Stimulating Hormone

Synthesis of analogues of the melanocyte-stimulating hormone release-inhibiting factor containing 2-oxoimidazolidine-1-carboxylic acid

1980 ◽  
Vol 45 (1) ◽  
pp. 294-297 ◽  
Author(s):  
Evžen Kasafírek ◽  
Ivan Krejčí ◽  
Vladimír Felt
Keyword(s):  
Amino Acid ◽  
Carboxylic Acid ◽  
Amino Acid Esters ◽  
Hormone Release ◽  
Melanocyte Stimulating Hormone ◽  
Inhibiting Factor ◽  
Carbonyl Chloride ◽  
Acid Esters ◽  
Stimulating Hormone

2-Oxoimidazolidine-1-carbonyl-leucyl-glycine amide (I), 2-oxoimidazolidine-1-carbonyl-leucyl-β-alanine amide (II), and 2-oxoimidazolidine-1-carbonyl-leucine amide (III) were synthesized by the acylation of corresponding dipeptide or amino-acid esters with 2-oxoamidazolidine-1-carbonyl chloride and following ammonolysis. Analogues I and II, containing 2-oxoimidazolidine-1-carboxylic acid instead of proline, exhibited the antiamnestic activity in the doses of 1 mg per kg subcutaneously, III was without effect.

THYROTROPHIN RELEASING FACTOR (TRF) IN CEREBROSPINAL FLUID OF THE 3RD VENTRICLE OF RAT

1974 ◽  
Vol 76 (2) ◽  
pp. 209-213 ◽  
Author(s):  
K. M. Knigge ◽  
S. A. Joseph
Keyword(s):  
Cerebrospinal Fluid ◽  
Drinking Water ◽  
Median Eminence ◽  
Cold Exposure ◽  
Male Rats ◽  
Assay Method ◽  
Normal Male ◽  
3Rd Ventricle ◽  
Pooled Samples

ABSTRACT The concentration of TRF in cerebrospinal fluid (CSF) of the 3rd ventricle and content of TRF in median eminence of the rat was examined. CSF (0.3–0.5 μl per animal) was collected from the 3rd ventricle by a microcannula technique and pooled samples from 10–15 animals were examined for TRF using an in vitro pituitary assay method. TRF concentration in 3rd ventricle CSF of normal male rats was 18.5 ± 4.2 pg/μl; median eminence contained 115 ± 12 pg. Cold exposure (4°C) for 16–18 h and thyroxine treatment (2.5 μg/day) for 5 days markedly reduced TRF concentration in CSF and content in the median eminence. Treatment with the anti-thyroid drug methimazole (0.01 % in the drinking water) for 5 days did not notably affect TRF in CSF or median eminence.

Sign in / Sign up

Export Citation Format

Share Document